Brief: Herantis Pharma Announces Successful Results With Nanoform Technology

Nanoform Finland Oyj

09/09/2021 06:18

Sept 9 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA ANNOUNCES SUCCESSFUL RHCDNF RESULTS WITH
NANOFORM TECHNOLOGY
    * INITIAL RESULTS FROM NANOFORM POC PROJECT SHOW THAT
NANOFORMING
PROCESS CAN BE SUCCESSFULLY APPLIED TO RHCDNF
    * HAVING ESTABLISHED THAT NANOFORMED RHCDNF NANOPARTICLES
RETAIN
STABILITY AND ACTIVITY MEANS PROJECT WILL MOVE ON TO NEXT
PRE-CLINICAL PHASE

Source text for Eikon:  ID:nWkrbSkPjx 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))